Data Foundry

Medical device recalls 2018

ADVIA Centaur BNP — Class II medical device recall Z-2053-2018

Ongoing recall by Siemens Healthcare Diagnostics, Inc., reported 2018-06-13, distributed in AL, CA, DE, GA, IA, IL, IN, KY…. In certain scenarios the ADVIA Centaur CP, XP and XPT immunoassay analyzers may exhibit reduced dilution recov

Recall numberZ-2053-2018
Product typeMedical device
ClassificationClass II
StatusOngoing
Voluntary or mandatedVoluntary
Recalling firmSiemens Healthcare Diagnostics, Inc., Tarrytown, NY, United States
Recall initiated2017-12-18
Classified2018-06-01
Reported by FDA2018-06-13
DistributedAL, CA, DE, GA, IA, IL, IN, KY, MA, MI, MS, MT, NC, ND, NJ, NM, NV, NY, OH, PA, PR, RI, TN, TX, VA, WA, WV, WY
Countries outside the USAE, AU, BE, CA, CH, CL, DE, ES, FR, GR, IL, IT, JP, LU, LV, NL, NO, NZ, PL, PT, RO, SG, SK, ZA
Quantity21,687
Model numbers02816138

Product

ADVIA Centaur BNP (B-type Natriuretic Peptide), Catalog Numbers: 02816138 (100 tests), 02816634 (500 tests)

Reason for recall

In certain scenarios the ADVIA Centaur CP, XP and XPT immunoassay analyzers may exhibit reduced dilution recovery or become inoperable when used with Multi-Diluent 15 and certain lots of BNP and TSH3RUL Assays.

Machine access

This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/Z-2053-2018. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.

Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.